HIGH BINDING OF IMMUNOGLOBULIN M-KAPPA RHEUMATOID-FACTOR FROM TYPE-IICRYOGLOBULINS TO CELLULAR FIBRONECTIN - A MECHANISM FOR INDUCTION OF IN-SITU IMMUNE-COMPLEX GLOMERULONEPHRITIS
A. Fornasieri et al., HIGH BINDING OF IMMUNOGLOBULIN M-KAPPA RHEUMATOID-FACTOR FROM TYPE-IICRYOGLOBULINS TO CELLULAR FIBRONECTIN - A MECHANISM FOR INDUCTION OF IN-SITU IMMUNE-COMPLEX GLOMERULONEPHRITIS, American journal of kidney diseases, 27(4), 1996, pp. 476-483
In our previous experimental work we suggested that the frequent nephr
itogenicity of type II cryoglobulins could depend on a particular affi
nity of the immunoglobulin (Ig) MK rheumatoid factor (RF) component fo
r mesangial matrix. Since cellular fibronectin (cFN) in the human kidn
ey is mainly represented in glomerular mesangium, we studied the bindi
ng capacity to cFN of IgM kappa RFs from type II cryoglobulins compare
d with other different monoclonal and polyclonal IgM and IgM RFs. We p
urified 13 IgM kappa from human IgM kappa/IgG cryoglobulins, eight mon
oclonal IgM from patients with Waldenstrom's macroglobulinemia, nine p
olyclonal IgM from normal donors, and eight polyclonal IgM RFs from pa
tients with rheumatoid arthritis. Purified IgM were used at the same c
oncentration in enzyme-linked immunosorbent assay (ELISA) on cFN-coate
d plates. All the cryoglobulin IgM showed high specific binding to cFN
while IgM from Waldenstrom's macroglobulinemia, normal IgM, and polyc
lonal IgM RFs had low or absent binding. These data were confirmed by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis of cFN follo
wed by Western blot analysis with purified IgM. The IgM kappa binding
to cFN persisted using IgM kappa monomers, and was inhibited by cFN bu
t not by plasma FN in a specific inhibition test. Further enzyme-linke
d immunosorbent assay studies showed that cryoglobulin IgM kappa RFs a
re still able to bind IgG in a dose-dependent manner once linked to so
lid-phase cFN. The data suggest that the affinity of cryoglobulin IgM
kappa RFs for immobilized cFN could be involved in the particular high
nephritogenicity of type II cryoglobulins and might lead to in situ i
mmune complex formation, (C) 1996 by the National Kidney Foundation, I
nc.